Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular acid-base balance refers to the regulation of the pH in the body's extracellular fluid (ECF), which is essential for maintaining normal physiological function and cellular metabolism. The ECF includes blood plasma and interstitial fluid, and its pH is tightly regulated within a narrow range (typically 7.35–7.45) to prevent protein denaturation, enzyme malfunction, and disruption of ion channels. The body uses buffer systems (bicarbonate/carbon dioxide, plasma proteins, phosphate), respiratory regulation (CO2 exhalation), and renal regulation (acid/base excretion/reabsorption) to maintain this balance. Key players include carbonic anhydrases, Na+/bicarbonate cotransporters, anion exchangers, and proton pumps. Disorders like acidemia and alkalemia arise when regulatory mechanisms fail, often due to respiratory, renal, or metabolic disturbances.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Acid-Base Balance.